Brief: Tetra Bio-Pharma Receives Favorable Letter Of Advice From Usa FDA For Qixleef
13/01/2020 13:16
Jan 13 (Reuters) - Tetra Bio Pharma Inc TBP.V :
* TETRA BIO-PHARMA RECEIVES FAVORABLE LETTER OF ADVICE FROM
USA
FDA FOR QIXLEEF
Source text for Eikon: ID:nGNXbbVGBx
Further company coverage: TBP.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tetra Bio Pharma
See all newsBrief: Tetra Bio Receives A Second Clarifax From Health Canada Regarding Reduvo Risk Management Plan
Brief: Tetra Bio-Pharma Announces Results Of Artificial Intelligence Study Of ARDS-003 Combined With Favipiravir
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra And Prepaire Jointly Apply To Barda For Funding